Small cell neuroendocrine carcinoma of the bladder with synchronous Warthin's tumor of the parotid gland: A rare case and overview of the literature

Basit Öğe Kaydı
dc.contributor.authorAytekin, Esra Cobankent
dc.contributor.authorAraz, Murat
dc.date.accessioned2024-02-23T14:41:50Z
dc.date.available2024-02-23T14:41:50Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractIntroduction. Neuroendocrine tumors (NETs) develop from the epithelium rich in enterochromaffin cells. NETs most commonly originate from the gastrointestinal and respiratory tract. NETs rarely occur in the urinary bladder. Synchronous tumor is defined as having two different tumors growing at the same time in an organ. NETs are frequently associated with synchronous or metachronous second-primary malignancies. In this paper, we describe a synchronous tumor: a small cell neuroendocrine carcinoma (SCNEC) of the bladder and a Warthin's tumor (WT) of the parotid gland, both of which are highly rare in the literature. Case report. A 79-year-old male patient was admitted to the hospital with gross hematuria and nodular mass involving the wall of the urinary bladder. The bladder neck resection and transurethral bladder resection (TURB) were performed. The tumor consisted of small, uniform, round, and spindled-shaped cells with chromatin dark nuclei and numerous mitotic figures. The cells were immunoreactive for CD56, synaptophysin (diffuse), and keratin (focal). The diagnosis of SCNEC with focal urothelial carcinoma in situ component was established. PET-CT was performed for staging purposes, and it showed a residual/recurrent tumor behind the lumen of the bladder floor and two nodular lesions with metabolic activity in the left parotid. After the biopsy of the parotid gland, it was diagnosed as WT. No metastasis of SCNEC was found at the time of diagnosis, and the patient received four cycles of induction chemotherapy (Etoposide combined with carboplatin chemotherapy) followed by chemoradiotherapy. Conclusion. In this case report, an extremely rare case of primary SCNEC of the bladder with synchronous of the parotid gland is presented, along with a discussion on the clinical presentation, immunohistochemical and cytomorphological characteristics, management, biological behavior, and prognosis.en_US
dc.identifier.doi10.5603/OCP.2022.0002
dc.identifier.endpage133en_US
dc.identifier.issn2450-1654
dc.identifier.issn2450-6478
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85130183710en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage128en_US
dc.identifier.urihttps://doi.org/10.5603/OCP.2022.0002
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17032
dc.identifier.volume18en_US
dc.identifier.wosWOS:000799975500001en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherVia Medicaen_US
dc.relation.ispartofOncology In Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSmall Cell Bladder Carcinomaen_US
dc.subjectSmall Cell Carcinomaen_US
dc.subjectSynchronous Cancersen_US
dc.subjectWarthin's Tumoren_US
dc.subjectUrothelial Carcinoma In Situen_US
dc.titleSmall cell neuroendocrine carcinoma of the bladder with synchronous Warthin's tumor of the parotid gland: A rare case and overview of the literatureen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu